| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.900 | 5.101 | 5.351 | 6.198 | 6.483 | 3.754 | 6.116 | 6.578 | 7.200 | 6.662 |
| Total Income - EUR | 4.900 | 5.101 | 5.351 | 6.198 | 6.483 | 3.754 | 6.116 | 6.578 | 7.200 | 6.662 |
| Total Expenses - EUR | 4.925 | 5.097 | 5.561 | 4.743 | 4.533 | 3.216 | 5.715 | 5.433 | 5.412 | 6.714 |
| Gross Profit/Loss - EUR | -25 | 4 | -210 | 1.455 | 1.950 | 538 | 401 | 1.145 | 1.789 | -52 |
| Net Profit/Loss - EUR | -172 | -149 | -371 | 1.269 | 1.755 | 433 | 345 | 998 | 1.502 | -52 |
| Employees | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Doramar Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.271 | 4.332 | 4.372 | 4.846 | 4.606 | 4.385 | 5.020 | 6.430 | 6.878 | 7.103 |
| Inventories | 3.462 | 3.931 | 3.947 | 4.139 | 4.492 | 4.292 | 4.384 | 4.750 | 5.906 | 6.045 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 809 | 401 | 424 | 708 | 113 | 93 | 637 | 1.680 | 972 | 1.058 |
| Shareholders Funds | -5.288 | -5.383 | -5.663 | -4.290 | -2.451 | -1.972 | -1.583 | -589 | 915 | 857 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.558 | 9.715 | 10.034 | 9.136 | 7.057 | 6.358 | 6.603 | 7.020 | 5.963 | 6.246 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Doramar Intermed Srl